You are here
Cutting-edge drugs to be fast-tracked, bypassing NICE
Cutting-edge drugs to be fast-tracked, bypassing NICE
15 July 2009
The UK government has announced plans to allow highly innovative drugs to be made available on the NHS for a limited period without going through appraisal by the National Institute for Health and Clinical Excellence (NICE).
This new initiative, called the Innovation Pass, will be made available for drugs to treat small patient populations – such as late-stage cancers – which have the potential to deliver improved patient outcomes but where a lack of cost-effectiveness data is limiting market access, under proposals announced yesterday.
--
Some more commentaries in the Blogs: ...invivoblog.blogspot.com